Efficacy prediction of systemic immune-inflammation index and prognostic nutritional index in breast cancer patients and their variations after neoadjuvant chemotherapy
In breast cancer patients receiving neoadjuvant chemotherapy, ΔPNI-ΔSII score is an effective predictor of efficacy, which helps to identify high-risk groups and evaluate efficacy.
Authors
- Conghui Jin
- Jingyi Ni
- Xinghui Li (ORCID: https://orcid.org/0000-0001-6451-7453)
- Li Song
- Weiwei Xu (ORCID: https://orcid.org/0000-0002-9587-6683)
- Xunlei Zhang (ORCID: https://orcid.org/0000-0002-2966-0614)
- Qi Xue (ORCID: https://orcid.org/0000-0002-1383-7171)
Institutions
- Nantong University (CN)
- Nantong Tumor Hospital (CN)
Publication Details
- Journal
- Frontiers in Immunology
- Published
- 2025-05-09
- DOI
- https://doi.org/10.3389/fimmu.2025.1514736
- Citations
- 7
- Primary Topic
- Inflammatory Biomarkers in Disease Prognosis
- Type
- article
- Field-Weighted Citation Impact
- 7.32